Avience Biomedicals IPO Subscription
The Avience Biomedicals IPO subscription reflects the demand received from different investor categories during the bidding period. The subscription data includes the number of shares offered, shares bid for, and the subscription multiple (X) for categories such as Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs).
As per the latest subscription update, the Avience Biomedicals IPO has received bids for 37,06,80,000 shares against 9,61,800 shares offered, resulting in an overall subscription of 385.4x. the NII category is subscribed 597.63x, Retail Investors 401.36x, and QIBs 196.77x. Within the NII category, BNII is subscribed 670.77x, while SNII is subscribed 451.35x.
- Retail
- 401.36x
- NII
- 597.63x
- QIB
- 196.77x
- Total
- 385.4x
Current GMP
₹145 (+69.71%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Avience Biomedicals IPO Subscription Details ( Mon, 22 Jun 26 01:51 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 273,600 | 53,837,400 | 196.77x |
| Non-Institutional | 207,000 | 123,709,800 | 597.63x |
| BNII (>₹10L) | 138,000 | 92,566,800 | 670.77x |
| SNII (₹2L–₹10L) | 69,000 | 31,143,000 | 451.35x |
| Retail Investors | 481,200 | 193,132,800 | 401.36x |
| Total | 961,800 | 370,680,000 | 385.4x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Application Wise Breakup (Approximate)
| Category | Reserved Apps | Applied Apps | Times (x) |
|---|---|---|---|
| Non-Institutional | 115 | 31,836 | 276.83x |
| BNII (>₹10L) | 77 | 16,492 | 215.11x |
| SNII (₹2L–₹10L) | 38 | 15,344 | 400.28x |
| Retail Investors | 401 | 160,944 | 401.36x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Shares bids Against Offered
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Where Can I Check the Avience Biomedicals IPO Live Subscription Status?
You can check the Avience Biomedicals IPO live subscription status on the IPO Master App or the official websites of the NSE. The live subscription data is updated regularly during the IPO bidding period and displays category-wise subscription figures for Retail Individual Investors (RII), Non-Institutional Investors (NII), Qualified Institutional Buyers (QIB), Employees (if applicable), and the overall IPO subscription.
What is Avience Biomedicals IPO retail subscription status?
The Retail Individual Investor (RII) portion of the Avience Biomedicals IPO was subscribed 401.36 times as of Mon, Jun 22, 2026 07:21 PM. The public issue closed on Mon, Jun 22, 2026 for bidding.
How to subscribe Avience Biomedicals IPO?
Investors can apply for the Avience Biomedicals IPO online through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or via UPI using a SEBI-registered stockbroker or trading app. Select the desired lot size, enter your bid within the price band, and submit your application during the IPO subscription period. The application amount remains blocked in your bank account until the IPO allotment process is completed.
How many times Avience Biomedicals IPO subscribed?
The Avience Biomedicals IPO was subscribed 385.4x times at the close of bidding period on Mon, Jun 22, 2026.
How to check Avience Biomedicals IPO allotment?
The Avience Biomedicals IPO allotment was finalized on Tue, Jun 23, 2026. You can check the Avience Biomedicals IPO allotment status on the registrar's website or the BSE/NSE websites using your PAN, application number, or DP/Client ID. You can also check the allotment status quickly through the IPO Master App.
When Will the Avience Biomedicals IPO Be Listed?
The Avience Biomedicals IPO was listed on Thu, Jun 25, 2026, on the NSE.
What is the Avience Biomedicals IPO Qualified Institutional Buyers (QIB) subscription status?
The Qualified Institutional Buyers (QIB) category of Avience Biomedicals IPO was subscribed 196.77 times as of Mon, Jun 22, 2026 07:21 PM.